Loading...
Docoh

TherapeuticsMD (TXMD)

Employees
Data from SEC filings
Employee count
CEO pay ratio
CEO Salary
Median Employee Salary
Shareholder alignment
Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM
On May 27, 2021, the Company held the Annual Meeting. At the close of business on April 5, 2021, the record date for the determination of stockholders entitled to vote at the Annual Meeting, there were 393,190,188 shares of Common Stock outstanding and entitled to vote at the Annual Meeting. The holders of 262,186,558 shares of Common Stock were represented virtually or by proxy at the Annual Meeting, constituting a quorum. At the Annual Meeting, the stockholders of the Company considered and voted on proposals to: (1) elect nine directors to serve until the Company’s next annual meeting of stockholders or until their successors are duly elected and qualified; (2) approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers for the fiscal year ended December 31, 2020; (3) approve a stock option exchange program for those employees of the Company who are not named executive officers (the “Non-Executive Option Exchange Program”); (4) approve the Amendment; and (5) ratify the appointment of Grant Thornton LLP, an independent registered public accounting firm, as the independent auditor of the Company for the fiscal year ending December 31, 2021.
Set forth below are the final voting results for each proposal submitted to a vote of the stockholders at the Annual Meeting. For more information on the following proposals, see the Proxy Statement.
Proposal 1: All of the nine nominees for the Company’s Board of Directors were elected to serve until the Company’s next annual meeting of stockholders or until their successors are duly elected and qualified, by the votes set forth in the table below:

NomineeForWithheldBroker
Non-Votes
Tommy G. Thompson126,246,42218,604,875117,335,261
Robert G. Finizio131,760,51113,090,786117,335,261
Paul M. Bisaro135,398,7169,452,581117,335,261
J. Martin Carroll126,680,60218,170,695117,335,261
Cooper C. Collins134,102,29510,749,002117,335,261
Karen L. Ling135,148,1049,703,193117,335,261
Jules A. Musing132,758,35512,092,942117,335,261
Gail K. Naughton, Ph.D.135,155,7709,695,527117,335,261
Angus C. Russell122,600,48922,250,808117,335,261
Proposal 2: The Company’s stockholders approved, on a non-binding, advisory basis, the compensation of the Company’s named executive officers for fiscal year ended December 31, 2020, by the votes set forth in the table below:

ForAgainstAbstainBroker Non-Votes
108,714,39431,639,1124,497,791117,335,261


Proposal 3: The Company’s stockholders approved the Non-Executive Option Exchange Program, by the votes set forth in the table below:

ForAgainstAbstainBroker Non-Votes
121,206,92922,372,3991,271,969117,335,261
Proposal 4: The Company’s stockholders approved the Amendment, by the votes set forth in the table below:

ForAgainstAbstainBroker Non-Votes
126,566,32717,584,675700,295117,335,261
Proposal 5: The Company’s stockholders ratified the appointment of Grant Thornton, LLP, an independent registered public accounting firm, as the independent auditor of the Company for the fiscal year ending December 31, 2021, by the votes set forth in the table below:

ForAgainstAbstainBroker Non-Votes
249,898,5149,142,2953,145,7490